top biopharmaceuticals for glp-1 medication 2025 Pharma Sales: Keytruda, GLP-1s, and Immunology Trends | Joanna Sadowska, PhD, EMBA posted on the topic Prescription GLP-1s for Weight Loss

Amgen updated data from its Phase I study of the weight loss drug AMG133 at the 2022 American Heart Association Annual Scientific Sessions (AHA)

At the same time, pharmaceutical companies are putting serious money into R and D, trying to bring in next-generation therapies and make results more consistent for patients

More product approvals are showing up, and demand keeps increasing for options that feel more patient friendly, and that combination keeps pushing the growth of oral GLP-1 treatments across countries

The study was sponsored by Eli Lilly and Company, the manufacturer of orforglipron and the injectable GLP-1 tirzepatide